Dr. Reddy's Laboratories is a publicly traded company trading on NYSE, led by CEO Erez Israeli.
Upcoming earnings announcement for Dr. Reddy's Laboratories
Past 12 earnings reports for Dr. Reddy's Laboratories
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | Q3 2026 | $0.16Est: $0.16 | +1.9% | $978.8MEst: $978.1M | +0.1% | — |
| Oct 24, 2025 | Q2 2026 | $0.19Est: $0.18 | +5.6% | $992.0MEst: $982.9M | +0.9% | — |
| Jul 23, 2025 | Q1 2026 | $0.20Est: $0.18 | +11.1% | $997.0MEst: $950.9M | +4.8% | — |
| May 9, 2025 | Q4 2025 | $0.22Est: $0.20 | +10.0% | $996.0MEst: $866.5M | +14.9% | — |
| Jan 23, 2025 | Q3 2025 | $0.20Est: $0.20 | 0.0% | $977.0MEst: $875.2M | +11.6% | — |
| Nov 5, 2024 | Q2 2025 | $0.18Est: $0.20 | -10.0% | $957.0MEst: $909.2M | +5.3% | — |
| Jul 27, 2024 | Q1 2025 | $0.20Est: $0.18 | +11.1% | $919.9MEst: $872.9M | +5.4% | — |
| May 7, 2024 | Q4 2024 | $0.19Est: $0.16 | +18.8% | $850.0MEst: $853.3M | -0.4% | — |
| Jan 30, 2024 | Q3 2024 | $0.20Est: $0.16 | +25.0% | $867.0MEst: $825.9M | +5.0% | — |
| Oct 27, 2023 | Q2 2024 | $0.21Est: $0.17 | +23.5% | $828.0MEst: $819.3M | +1.1% | — |
| Jul 26, 2023 | Q1 2024 | $0.21Est: $0.14 | +50.0% | $821.0MEst: $783.7M | +4.8% | — |
| May 10, 2023 | Q4 2023 | $0.14Est: $0.13 | +7.7% | $766.0MEst: $742.2M | +3.2% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.